Medline (FRA:L10) Inventories, Raw Materials & Components: €722 Mil (As of Mar. 2026)


FRA:L10 Medline Inc FRA:L10
14 GF Score
Price €32.60
! 3 Warning Signs
View Full Analysis

What is Medline Inventories, Raw Materials & Components?

Medline FRA:L10 +5.16% 14 Inventories, Raw Materials & Components is €722 Mil as of Mar. 2026. GuruFocus rates FRA:L10 with a GF Score™ of 14/100. The stock has 3 warning signs investors should review.

Medline's inventories, raw materials & components for the quarter that ended in Mar. 2026 was €722 Mil.

Medline's quarterly raw materials declined from Sep. 2025 (€640 Mil) to Dec. 2025 (€639 Mil) but then increased from Dec. 2025 (€639 Mil) to Mar. 2026 (€722 Mil).

Medline's annual raw materials increased from Dec. 2023 (€615 Mil) to Dec. 2024 (€646 Mil) but then declined from Dec. 2024 (€646 Mil) to Dec. 2025 (€639 Mil).

Medline Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Medline's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medline Inventories, Raw Materials & Components Chart

Medline Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
0.00 615.31 645.58 638.79

Medline Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only 0.00 619.04 639.85 638.79 722.28
FRA:L10
14GF Score
Medline Inc FRA:L10
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medline Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of €722 Mil mean?
Medline (FRA:L10) has a Inventories, Raw Materials & Components of €722 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Medline and its competitors.
Is Medline's Inventories, Raw Materials & Components too high?
Medline's current Inventories, Raw Materials & Components is €722 Mil. Overall, Medline has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Inventories, Raw Materials & Components compare to RMD and WST?
Medline's Inventories, Raw Materials & Components of €722 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Medical Devices & Instruments company?
A good Inventories, Raw Materials & Components depends on the Medical Devices & Instruments industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Medline and its competitors. Medline's current Inventories, Raw Materials & Components is €722 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (FRA:L10) has a current Inventories, Raw Materials & Components of €722 Mil. The current Inventories, Raw Materials & Components is €722 Mil. Medline's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Medline (FRA:L10), the current Inventories, Raw Materials & Components is €722 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medline Business Description

Other Exchanges MDLN:USA
Address 3 Lakes Drive, Northfield, IL, USA, 60093
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
14GF Score

Get the complete analysis for FRA:L10

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.60
Price